ACTRN12613000343707招募中未知
For patients receiving the standard protocol of Hyperbaric Oxygen Therapy (HBOT), does the delivery of oxygen via hood induce a greater extent of ocular refractive change in patients than in patients who received oxygen via mask?
Michael Bennett0 个研究点目标入组 120 人开始时间: 2013年3月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 120
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomised controlled trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- o limit 至 o limit（—）
- 性别
- All
入选标准
- •HBOT indication of at least 20 sessions
- •Minimal visual acuity of 6/12 or better
- •Ability to receive HBOT via mask or hood
排除标准
- •Patient refusal to participate
- •Patients using topical eye treatments
研究者
相似试验
招募中
不适用
Treatment of Essential Hypertension Grade 2 with a Unani formulatioCTRI/2021/05/033481Prof Rais Ur Rahman
进行中（未招募）
不适用
A SU011248 TREATMENT PROTOCOL FOR PATIENTS WITH CYTOKINE-REFRACTORY METASTATIC RENAL CELL CARCINOMA WHO ARE INELIGIBLEFOR PARTICIPATION IN OTHER SU011248 PROTOCOLS AND MAY DERIVEBENEFIT FROM TREATMENT WITH SU011248Histopathologically confirmed renal cell carcinoma with metastasesMedDRA version: 8.0Level: LLTClassification code 10038415EUCTR2005-002097-30-ATPfizer Corporation Austria Ges.m.b.H.1,000
进行中（未招募）
不适用
A SU011248 TREATMENT PROTOCOL FOR PATIENTS WITH CYTOKINE- REFRACTORY METASTATIC RENAL CELL CARCINOMA WHO ARE INELIGIBLE FOR PARTICIPATION IN OTHER SU011248 PROTOCOLS AND MAY DERIVE BENEFIT FROM TREATMENT WITH SU011248Histopathologically confirmed renal cell carcinoma with metastasesMedDRA version: 8.0Level: LLTClassification code 10038415EUCTR2005-002097-30-IEPfizer Inc.1,000
已完成
Unknown
Study the effects of Unani treatment on HypertensioCTRI/2023/09/057350Ayurvedic and Unani tibbia college hospital40
尚未招募
2 期
Tranexemic acid for bloodless root canalCTRI/2018/01/011557Dr Roshni